Petros Pharmaceuticals Inc (PTPI)
0.58
+0.03
(+5.82%)
USD |
NASDAQ |
May 17, 16:00
0.58
0.00 (0.00%)
After-Hours: 17:36
Petros Pharmaceuticals Price to Free Cash Flow
Price to Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Free Cash Flow Data
| Date | Value |
|---|---|
| December 30, 2020 | -- |
| December 29, 2020 | -- |
| December 28, 2020 | -- |
| December 24, 2020 | -- |
| December 23, 2020 | -- |
| December 22, 2020 | -- |
| December 21, 2020 | -- |
| December 18, 2020 | -- |
| December 17, 2020 | -- |
| December 16, 2020 | -- |
| Date | Value |
|---|---|
| December 15, 2020 | -- |
| December 14, 2020 | -- |
| December 11, 2020 | -- |
| December 10, 2020 | -- |
| December 09, 2020 | -- |
| December 08, 2020 | -- |
| December 07, 2020 | -- |
| December 04, 2020 | -- |
| December 03, 2020 | -- |
| December 02, 2020 | -- |
Price to Cash Flow Definition
Price to free cash flow measures the Price / TTM Free Cash Flow. Like other price ratios (ie. PE Ratio, PS Ratio, P/B Ratio), this metric can be used to compare companies with similar capital structures. Free cash flow gives an idea of how much cash is available for shareholders through stock buybacks and dividend payouts. A lower price to free cash flow is more desirable when assessing different companies.
Price to Free Cash Flow Range, Past 5 Years
Price to Free Cash Flow Benchmarks
| Avalo Therapeutics Inc | -- |
| Imunon Inc | -- |
| iBio Inc | -- |
| Oramed Pharmaceuticals Inc | -- |
| Ocugen Inc | -- |